Literature DB >> 32871662

Cognitive remediation therapy for partially remitted unipolar depression: A single-blind randomized controlled trial.

Lena Listunova1, Johanna Kienzle2, Marina Bartolovic2, Anna Jaehn2, Thea Marianne Grützner2, Robert Christian Wolf3, Steffen Aschenbrenner4, Matthias Weisbrod5, Daniela Roesch-Ely2.   

Abstract

BACKGROUND: There is an urgent need for the development and evaluation of targeted interventions for cognitive impairment (CI) in patients with (partially) remitted major depressive disorder (MDD). The aim of our study was therefore to evaluate the effect of cognitive remediation therapy (CRT) on cognitive and psychosocial functioning in a sample of patients with MDD, taking into account comorbidity, psychopathology, remission status and CI profile. Furthermore, we compared a generalized training (GT) with an individualized training (IT) approach regarding their effects on cognition.
METHODS: Sixty-two MDD patients in partial remission with CI were randomly assigned to a control group (CG), IT or GT. Participants of GT trained six cognitive subdomains (divided attention, selective attention, alertness, working memory, planning and response inhibition), whereas participants of IT trained their three most deficient cognitive subdomains as identified at baseline. Participants of both intervention groups trained three times per week over a five-week period. Both training groups received additional 30-minute compensatory-transfer sessions once per week.
RESULTS: Attention appeared to be the most frequently impaired cognitive domain as well as the domain which was significantly improved by CRT, with medium to large effect sizes. No difference in improvement was found between IT and GT. The analyses also revealed greater improvement in self-assessed psychosocial functioning in training participants (GT and IT combined) compared to the CG. LIMITATIONS: Due to the small sample size, the present results are preliminary in nature.
CONCLUSION: CRT was well accepted, and patients transferred the attentional improvement to real life, as measured by self-assessed psychosocial functioning. IT yielded no additional advantages over GT. We propose CRT as an integral part of the treatment plan for patients with depression suffering from CI.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Cognition disorders; Cognitive remediation; Depressive disorder; Psychosocial functioning; Remission

Year:  2020        PMID: 32871662     DOI: 10.1016/j.jad.2020.07.008

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  5 in total

1.  In pursuit of full recovery in major depressive disorder.

Authors:  Vicent-Gil M; Serra-Blasco M; Navarra-Ventura G; Trujols J; Balanzá-Martínez V; Portella Mj; Cardoner N
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-09       Impact factor: 5.760

2.  Augmenting neurocognitive remediation therapy to Preventive Cognitive Therapy for partially remitted depressed patients: protocol of a pragmatic multicentre randomised controlled trial.

Authors:  Claudi Bockting; Amanda M Legemaat; Johanne G J van der Stappen; Gert J Geurtsen; Maria Semkovska; Huibert Burger; Isidoor O Bergfeld; Nicoline Lous; Damiaan A J P Denys; Marlies Brouwer
Journal:  BMJ Open       Date:  2022-06-23       Impact factor: 3.006

3.  Predictors of Treatment Response to an Internet-Delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder.

Authors:  Sunniva Brurok Myklebost; Rolf Gjestad; Yavuz Inal; Åsa Hammar; Tine Nordgreen
Journal:  Front Psychiatry       Date:  2022-03-28       Impact factor: 4.157

4.  Artificial Cognitive Systems Applied in Executive Function Stimulation and Rehabilitation Programs: A Systematic Review.

Authors:  Luis F Castillo-Ossa; Juan M Corchado; Carolina Robledo-Castro
Journal:  Arab J Sci Eng       Date:  2022-09-28       Impact factor: 2.807

Review 5.  Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force.

Authors:  Kamilla W Miskowiak; Ida Seeberg; Mette B Jensen; Vicent Balanzá-Martínez; Caterina Del Mar Bonnin; Christopher R Bowie; Andre F Carvalho; Annemieke Dols; Katie Douglas; Peter Gallagher; Gregor Hasler; Beny Lafer; Kathryn E Lewandowski; Carlos López-Jaramillo; Anabel Martinez-Aran; Roger S McIntyre; Richard J Porter; Scot E Purdon; Ayal Schaffer; Paul Stokes; Tomiki Sumiyoshi; Ivan J Torres; Tamsyn E Van Rheenen; Lakshmi N Yatham; Allan H Young; Lars V Kessing; Katherine E Burdick; Eduard Vieta
Journal:  Bipolar Disord       Date:  2022-02-24       Impact factor: 5.345

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.